Mitogenic activity of high molecular weight forms of insulin-like growth factor-II in amniotic fluid

Journal of Endocrinology

Volumn 169, Issue 3, 2001, Pages 563-572

  Blahovec, J ^a   Kostecka, Z ^a   Lacroix, M C ^a   Cabanie, L ^a   Godeau, F ^a   Mester, J ^a   Cavaille F ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C;

AMNION FLUID; ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; EVOLUTION; FETUS DEVELOPMENT; FIBROBLAST; FRACTIONATION; GEL PERMEATION CHROMATOGRAPHY; GESTATIONAL AGE; GOAT; MATURITY; MITOGENESIS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; SHEEP;

AMNIOTIC FLUID; ANIMALS; BIOLOGICAL ASSAY; CELL CULTURE TECHNIQUES; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GOATS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR II; MICE; MITOGENS; MITOSIS; MOLECULAR WEIGHT; PREGNANCY; SHEEP;

EID: 0034965855     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1690563     Document Type: Article

References (51)

1. The development of the gastrointestinal system in fetal sheep in the absence of ingested fluid
2. Disappearance of labelled IGF-2 from plasma of the ovine fetus in late gestation
3. Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: Relationship to fetal maturity
4. EMK protein kinase-null mice: Dwarfism and hypofertility associated with alterations in the somatotrope and prolactin pathways
5. Specific assay for insulin-like growth factor (IGF) II using the IGF binding proteins extracted from human cerebrospinal fluid
6. Peptide-like substances in sheep amniotic fluid which regulate proliferation of BP-A31 cells
7. Binding characteristics of pro-insulin-like growth factor-II from cancer patients: Binary and ternary complex formation with IGF binding proteins-1 to -6
8. Fibroblast growth factor-dependent mitogenic signal transduction pathway in chemically transformed mouse fibroblasts is similar to but distinct from that initiated by phorbol esters
9. Mitogenic activity of phorbol esters and insulin-like growth factor 1 in chemically transformed mouse fibroblasts BP-A31: Independent effects and differential sensitivity to inhibition by 3-isobutyl-1-methyl xanthine
10. Purification of a 31 000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions
11. Levels of insulin-like growth factor-binding protein-2 and insulin-like growth factor-II in maternal serum, amniotic fluid and extraembryonic coelomic fluid at 9-20 weeks of pregnancy
12. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia
13. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting
14. The expression of insulin-like growth factor (IGF)-binding protein-2 and IGF-II genes in the tissues of the developing ovine fetus
15. Somatomedin-C/insulin-like growth factor I-binding proteins in human amniotic fluid and in fetal and postnatal blood: Evidence of immunological homology
16. Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis
17. Growth and metabolism of the ovine placenta during mid-gestation
18. Mitogenic signaling by prostaglandins in chemically transformed mouse fibroblasts: Comparison with phorbol esters and insulin
19. Control of hepatic insulin-like growth factor II gene expression by thyroid hormones in fetal sheep near term
20. Respiration of amniotic fluid in near-term foetal rabbit
21. Evidence for two species of insulin-like growth factor II (IGF II and 'big' IGF II) in human spinal fluid
22. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150 K complex during pregnancy
23. The identification of O-glycosylated precursors of insulin-like growth factor II
24. Human amniotic fluid motogenic activity for fetal alveolar type II cells by way of hepatocyte growth factor
25. Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant
26. Insulin-like growth factors and their binding proteins: Biological actions
27. Role of epidermal growth factor and transforming growth factor alpha in the developing stomach
28. Enteral IGF-I enhances fetal growth and gastrointestinal development in oesophageal ligated fetal sheep
29. Effect of restriction of placental growth on expression of IGFs in fetal sheep: Relationship to fetal growth, circulating IGFs and binding proteins
30. Tumor hypoglycemia linked to IGF-II
31. Monoclonal antibodies to receptors for insulin and somatomedin-C
32. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
33. The role of the fetus in the formation of amniotic fluid
34. Characterization of proinsulin-like growth factor-II E-region immunoreactivity in serum and other biological fluids
35. Prolonged hypoxia induced by the reduction of maternal uterine blood flow alters insulin-like growth factor-binding protein-1 (IGFBP-1) and IGFBP-2 gene expression in the ovine fetus
36. Insulin-like growth factors in amniotic fluid
37. Hypophysectomy of the fetal lamb leads to a fall in the plasma concentration of insulin-like growth factor I (IGF-I), but not IGF-II
38. Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed IGFBP-3 in embryonic cavities in early human pregnancy: Their potential relevance to maternal-embryonic and fetal interactions
39. Developmental and tissue-specific regulation of ovine insulin-like growth factor II (IGF-II) mRNA expression
40. Circulating insulin-like growth factors-I and -II and substrates in fetal sheep following restriction of placental growth
41. Insulin-like growth factor binding proteins
42. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture
43. Tumor hypoglycemia: Relationship to high molecular weight insulin-like growth factor-II
44. Ultrastructural anomalies in the fetal small intestine indicate that fetal swallowing is important for normal development: An experimental study
45. The role of ingestion in the development of the small intestine in fetal sheep
46. Soluble insulin-like growth factor II/mannose 6-phosphate receptor carries multiple high molecular weight forms of insulin-like growth factor II in fetal bovine serum
47. Biophysical and biological properties of naturally occurring high molecular weight insulin-like growth factor II variants
48. Characterization of insulin-like growth factor-binding protein in ovine amniotic fluid
49. Role of the insulin-like growth factor system in uterine function and placental development in ruminants
50. Anatomy, physiology and pathology of the amniotic and allantoic compartments in the sheep and cow
51. Can 'big' insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?